Your browser doesn't support javascript.
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.
Hurlburt, Nicholas K; Homad, Leah J; Sinha, Irika; Jennewein, Madeleine F; MacCamy, Anna J; Wan, Yu-Hsin; Boonyaratanakornkit, Jim; Sholukh, Anton M; Jackson, Abigail M; Zhou, Panpan; Burton, Dennis R; Andrabi, Raiees; Ozorowski, Gabriel; Ward, Andrew B; Stamatatos, Leonidas; Pancera, Marie; McGuire, Andrew T.
  • Hurlburt NK; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • Homad LJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • Sinha I; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • Jennewein MF; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • MacCamy AJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • Wan YH; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • Boonyaratanakornkit J; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • Sholukh AM; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • Jackson AM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Zhou P; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Andrabi R; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
  • Ozorowski G; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Stamatatos L; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Pancera M; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. lstamata@fredhutch.org.
  • McGuire AT; Department of Global Health, University of Washington, Seattle, WA, USA. lstamata@fredhutch.org.
Commun Biol ; 5(1): 342, 2022 04 11.
Article in English | MEDLINE | ID: covidwho-1784032
ABSTRACT
Three betacoronaviruses have crossed the species barrier and established human-to-human transmission causing significant morbidity and mortality in the past 20 years. The most current and widespread of these is SARS-CoV-2. The identification of CoVs with zoonotic potential in animal reservoirs suggests that additional outbreaks could occur. Monoclonal antibodies targeting conserved neutralizing epitopes on diverse CoVs can form the basis for prophylaxis and therapeutic treatments and enable the design of vaccines aimed at providing pan-CoV protection. We previously identified a neutralizing monoclonal antibody, CV3-25 that binds to the SARS-CoV-2 spike, neutralizes the SARS-CoV-2 Beta variant comparably to the ancestral Wuhan Hu-1 strain, cross neutralizes SARS-CoV-1 and binds to recombinant proteins derived from the spike-ectodomains of HCoV-OC43 and HCoV-HKU1. Here, we show that the neutralizing activity of CV3-25 is maintained against the Alpha, Delta, Gamma and Omicron variants of concern as well as a SARS-CoV-like bat coronavirus with zoonotic potential by binding to a conserved linear peptide in the stem-helix region. Negative stain electron microscopy and a 1.74 Å crystal structure of a CV3-25/peptide complex demonstrates that CV3-25 binds to the base of the stem helix at the HR2 boundary to an epitope that is distinct from other stem-helix directed neutralizing mAbs.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines / Variants Limits: Animals Language: English Journal: Commun Biol Year: 2022 Document Type: Article Affiliation country: S42003-022-03262-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines / Variants Limits: Animals Language: English Journal: Commun Biol Year: 2022 Document Type: Article Affiliation country: S42003-022-03262-7